Asia-Pacific Exosome Therapeutic Market - Industry Trends and Forecast to 2026

Asia-Pacific Exosome Therapeutic Market - Industry Trends and Forecast to 2026

Short Description
Asia-Pacific Exosome Therapeutic Market By Type (Natural Exosomes, Hybrid Exosomes), Source (Dendritic Cells, Mesenchymal Stem Cells, Blood, Milk, Body Fluids, Saliva, Urine Others), Therapy (Immunotherapy, Gene Therapy, Chemotherapy), Transporting Capacity (Bio Macromolecules, Small Molecules), Application (Oncology, Neurology, Metabolic Disorders, Cardiac Disorders, Blood Disorders, Inflammatory Disorders, Gynecology Disorders, Organ Transplantation, Others), Route of Administration (Oral, Parenteral), End User (Hospitals, Diagnostic Centers, Research & Academic Institutes), Counties (South Korea, Hong Kong, Australia)
Market Definition:
Exosomes can be defined as small extracellular vesicles released from cells upon fusion of the multivesicular body (MVB), an intermediate endocytic compartment, with the plasma membrane and which are found in almost every eukaryotic fluid and helps to facilitate with cellular functions. Exosomes are used to transfer RNA, DNA, and proteins to other cells in the body by making alteration in the function of the target cells. Exosomes could be ranging from 30 nm on the low end to 100 nm on the high end. Exosome can be classified into natural exosomes and hybrid exosomes. Exosomes can be sourced from all body fluids, including: blood, urine, saliva, synovial fluid, amniotic fluid, semen, vaginal fluid, breast milk, serum and plasma, cultured medium of cell cultures, and other sourced. Exosome therapeutic can be used for the treatment of various diseases and disorders which includes gastric cancer, head and neck cancer, non-small cell lung cancer, breast cancer, Parkinson disease, alzheimer disease, metabolic disorders, cardiac disorders, blood disorders, inflammatory disorders, gynecology disorders, organ transplantation through oral and parenteral administration among others.
Market Segmentation:
Asia-Pacific exosome therapeutic market is categorized into seven notable segments which are based on the basis of type, source, therapy, transporting capacity, application, route of administration and end user.
• On the basis of type, the market is segmented into natural exosomes and hybrid exosomes.
• On the basis of source, the market is segmented into dendritic cells, mesenchymal stem cells, blood, milk, body fluids, saliva, urine and others.
• On the basis of therapy, the market is segmented into immunotherapy, gene therapy and chemotherapy.
• On the basis of transporting capacity the market is segmented into bio macromolecules and small molecules.
• On the basis of application, the market is segmented into oncology, neurology, metabolic disorders, cardiac disorders, blood disorders, inflammatory disorders, gynecology disorders, organ transplantation and others.
• On the basis of route of administration, the market is segmented into oral and parenteral.
• On the basis of end user, the market is segmented into hospitals, diagnostic centers and research & academic institutes and others.
Market Players
• Exopharm
• AEGLE Therapeutics
• United Therapeutics Corporation
• Codiak BioSciences
• Jazz Pharmaceuticals, Inc.
• Boehringer Ingelheim International GmbH
• ReNeuron Group plc
• Capricor Therapeutics
• Avalon Globocare Corp.
• Stem Cells Group

The single user license is non-downloadable and non-printable. Global Site license allows these actions.

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-pacific Exosome Therapeutic Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Products Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Secondary Sources
2.10 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Increasing Prevalence Of Lyme Disease, Chronic Inflammation, Autoimmune Disease And Other Chronic Degenerative Diseases
3.1.2 Increasing Demand For Anti-aging Therapy’s
3.2 Restraint
3.2.1 Unmet Medical Needs
3.3 Opportunities
3.3.1 Progressing Therapeutic Value Of Exosome
3.3.2 Availability Of Various Exosome Isolation And Purification Techniques
3.3.3 Technological Advancements In Exosome
3.3.4 Strategic Research Initiatives By Market Players
3.3.5 Rising Healthcare Infrastructure
3.4 Challenge
3.4.1 Lack Of Skilled Professional’s Required For The Isolation Of Exosome
4 Executive Summary
5 Premium Insights
6 Pipeline
7 Asia-pacific Exosome Therapeutic Market, By Type
7.1 Overview
7.2 Hybrid Exosomes
7.3 Natural Exosomes
7.3.1 Autologous Exosomes
7.3.2 Exogenous Exosomes
8 Asia-pacific Exosome Therapeutic Market, By Source
8.1 Overview
8.2 Mesenchymal Stem Cells
8.3 Dendritic Cells
8.4 Blood
8.4.1 B Lymphocytes
8.4.2 Others
8.5 Body Fluids
8.5.1 Synovial Fluid
8.5.2 Amniotic Fluid
8.5.3 Semen
8.5.4 Others
8.6 Milk
8.7 Saliva
8.8 Urine
8.9 Others
9 Asia-pacific Exosome Therapeutic Market, By Therapy
9.1 Overview
9.2 Chemotherapy
9.3 Immunotherapy
9.4 Gene Therapy
10 Asia-pacific Exosome Therapeutic Market, By Transporting Capacity
10.1 Overview
10.2 Bio Macromolecules
10.2.1 Nucleic Acids
10.2.2 Peptides
10.2.3 Proteins
10.3 Small Molecules
11 Asia-pacific Exosome Therapeutic Market, By Application
11.1 Overview
11.2 Oncology
11.2.1 Non-small Cell Lung Cancer
11.2.2 Breast Cancer
11.2.3 Gastric Cancer
11.2.4 Head And Neck Cancer
11.2.5 Others
11.3 Cardiac Disorders
11.4 Metabolic Disorders
11.5 Neurology
11.5.1 Parkinson's Disease
11.5.2 Alzheimer's Disease
11.5.3 Others
11.6 Blood Disorders
11.7 Gynecology Disorders
11.8 Inflammatory Disorders
11.9 Organ Transplantation
11.10 Others
12 Asia-pacific Exosome Therapeutic Market, By Route Of Administration
12.1 Overview
12.2 Parenteral
12.3 Oral
13 Asia-pacific Exosome Therapeutic Market, By End User
13.1 Overview
13.2 Hospitals
13.3 Research & Academic Institutes
13.4 Diagnostic Centers
14 Asia-pacific Exosome Therapeutic Market, By Geography
14.1 Asia-pacific
14.1.1 South Korea
14.1.2 Hong Kong
14.1.3 Australia
15 Asia-pacific Exosome Therapeutic Market, Company Landscape
15.1 Company Share Analysis: Asia-pacific
16 Company Profile
16.1 Stem Cells Group
16.1.1 Company Snapshot
16.1.2 Product Portfolio
16.1.3 Recent Development
16.2 Exocobio
16.2.1 Company Snapshot
16.2.2 Product Portfolio
16.2.3 Recent Development
16.3 Aegle Therpeutics
16.3.1 Company Snapshot
16.3.2 Pipeline Portfolio
16.4 Avalon Globocare Corp.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Pipeline Portfolio
16.4.4 Recent Development
16.5 Boehringer Ingelheim International Gmbh
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Product Portfolio
16.5.4 Recent Development
16.6 Capricor Therapeutics
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Developments
16.7 Codiak Biosciences
16.7.1 Company Snapshot
16.7.2 Pipeline Portfolio
16.7.3 Recent Developments
16.8 Creative Medical Technology Holdings, Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Pipeline Portfolio
16.8.4 Recent Development
16.9 Exopharm
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Pipeline Portfolio
16.9.4 Recent Development
16.10 Evox Therapeutics
16.10.1 Company Snapshot
16.10.2 Pipeline Portfolio
16.10.3 Recent Developments
16.11 Jazz Pharmaceuticals, Inc.
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Development
16.12 Reneuron Group Plc
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Development
16.13 United Therapeutics Corporation
16.13.1 Company Snapshot
16.13.2 Revenue Analysis
16.13.3 Product Portfolio
16.13.4 Recent Development
17 Questionnaire
18 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook